STMN 📈 Straumann Holding - Overview

Exchange: SW • Country: Switzerland • Currency: CHF • Type: Common Stock • ISIN: CH1175448666

STMN: Dental Implants, Orthodontic Aligners, Biomaterials, Digital Solutions

Straumann Holding AG is a global leader in the development, manufacture, and supply of tooth replacement and orthodontic solutions, catering to the needs of dental professionals and patients worldwide. The company's extensive product portfolio encompasses a wide range of dental implants, instruments, and digital solutions, including CADCAM prosthetics, orthodontic aligners, biomaterials, and resins for 3D printing. By leveraging cutting-edge technologies, Straumann enables dental professionals to provide high-quality, personalized treatments, from tooth correction and replacement to restoration and prevention of tooth loss.

The company's product lineup includes dental implants and components fabricated from high-quality materials such as titanium, titanium alloy, and ceramics, as well as prosthetic elements made from ceramics, metal, or polymer. Additionally, Straumann offers clear aligners, resins for 3D printing, and thermoplastics for clear aligner production, allowing for precise and efficient dental restorations. Its biomaterials portfolio supports tissue generation, further expanding the possibilities for dental reconstruction and regeneration. Moreover, the company provides digital equipment, including scanners, milling machines, and 3D printers, which facilitate the creation of customized dental prosthetics and implants.

Straumann's commitment to education and training is reflected in its comprehensive services, designed to support dental professionals in staying up-to-date with the latest technologies and techniques. The company's global reach extends to approximately 100 countries, where its products and services are distributed through a network of subsidiaries and partners, serving a diverse customer base that includes general dentists, specialists, dental technicians, laboratories, distributors, hospitals, universities, and dental service organizations. With a rich history dating back to 1954, Straumann Holding AG is headquartered in Basel, Switzerland, and has established itself as a trusted and innovative player in the global dental industry.

As a publicly traded company, Straumann Holding AG is listed under the ISIN CH1175448666, with its common stock classified under the GICS Sub Industry: Health Care Equipment. This classification underscores the company's focus on developing and manufacturing medical devices and equipment that cater to the needs of the healthcare sector. With its strong online presence, including its website at https://www.straumann.com, Straumann provides easy access to information on its products, services, and initiatives, facilitating communication and collaboration with its global customer base and stakeholders.

Additional Sources for STMN Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

STMN Stock Overview

Market Cap in USD 20,691m
Sector Healthcare
Industry Medical Instruments & Supplies
GiC Sub-Industry Health Care Equipment
IPO / Inception

STMN Stock Ratings

Growth 5y 10.8%
Fundamental 72.4%
Dividend 55.7%
Rel. Strength Industry -788
Analysts -
Fair Price Momentum 94.02 CHF
Fair Price DCF 67.41 CHF

STMN Dividends

Dividend Yield 12m 0.75%
Yield on Cost 5y 0.91%
Annual Growth 5y 8.79%
Payout Consistency 94.8%

STMN Growth Ratios

Growth Correlation 3m -68.9%
Growth Correlation 12m -57.5%
Growth Correlation 5y 39.1%
CAGR 5y 4.13%
CAGR/Mean DD 5y 0.15
Sharpe Ratio 12m -0.55
Alpha -48.61
Beta 1.29
Volatility 31.72%
Current Volume 407.1k
Average Volume 20d 292.1k
What is the price of STMN stocks?
As of December 21, 2024, the stock is trading at CHF 113.85 with a total of 407,050 shares traded.
Over the past week, the price has changed by -3.65%, over one month by +2.39%, over three months by -11.70% and over the past year by -16.05%.
Is Straumann Holding a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Straumann Holding (SW:STMN) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 72.37 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of STMN as of December 2024 is 94.02. This means that STMN is currently overvalued and has a potential downside of -17.42%.
Is STMN a buy, sell or hold?
Straumann Holding has no consensus analysts rating.
What are the forecast for STMN stock price target?
According to ValueRays Forecast Model, STMN Straumann Holding will be worth about 105.8 in December 2025. The stock is currently trading at 113.85. This means that the stock has a potential downside of -7.11%.
Issuer Forecast Upside
Wallstreet Target Price 131.9 15.8%
Analysts Target Price - -
ValueRay Target Price 105.8 -7.1%